Orally Administrated Inulin-Modified Nanozymes for CT-Guided IBD Theranostics
Orally Administrated Inulin-Modified Nanozymes for CT-Guided IBD Theranostics
About this item
Full title
Author / Creator
Li, Xinwen , Cao, Lin , Li, Jianmin , Li, Zhengyang , Ma, Hongyu , Cheng, Shifeng , Xu, Hongyi and Zhao, Yang
Publisher
New Zealand: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease with no clinical cure. Excessive production of reactive oxygen species (ROS) at the inflammatory sites leads to the onset and progression of IBD. And the current non-invasive imaging methods are not ideal for the diagnosis and monitoring of IBD.
Herein, we developed inulin...
Alternative Titles
Full title
Orally Administrated Inulin-Modified Nanozymes for CT-Guided IBD Theranostics
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11846537
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11846537
Other Identifiers
ISSN
1178-2013,1176-9114
E-ISSN
1178-2013
DOI
10.2147/IJN.S497558
